TickerFacts.

Company research / PBH

Prestige Consumer Healthcare Inc. (PBH)

Build a valuation ↗↓ Download CSV

CIK 0001295947 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, Prestige Consumer Healthcare Inc. reported revenue of $1.09B. Revenue fell 4.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.10B.

Key ratios (year ended 2026-03-31)

54.7%
Gross margin
28.4%
Operating margin
17.5%
Net margin
10.1%
Return on year-end equity
-4.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-14

Headquarters locality: Tarrytown · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenue$1.10B$1.09B$1.14B$1.13B$1.13B$1.09B$943.37M$963.01M$975.78M$1.04B$882.06M
Cost of Revenue$513.45M$493.13M$503.30M$500.91M$502.43M$466.17M$395.89M$410.79M$420.20M$464.67M$381.77M
Gross Profit$591.43M$595.58M$634.46M$624.45M$625.29M$620.65M$547.47M$552.22M$555.58M$576.50M$500.29M
Operating Income$290.17M$309.41M$336.77M$342.43M-$22.41M$329.92M$297.40M$291.15M$67.50M$215.47M$205.64M
Depreciation & Amortization$32.36M$31.27M$30.17M$30.68M$32.62M$32.09M$30.16M$29.00M$31.78M$33.43M$25.79M
EBITDA$322.53M$340.68M$366.95M$373.10M$10.21M$362.01M$327.57M$320.15M$99.28M$248.90M$231.44M
Net Income$172.01M$190.30M$214.60M$209.34M-$82.31M$205.38M$164.68M$142.28M-$35.80M$339.57M$69.39M
EPS (Diluted)n/a$3.91$4.29$4.17-$1.65$4.04$3.25$2.78-$0.69$6.34$1.30
Total Assets$4.57B$3.49B$3.40B$3.32B$3.35B$3.67B$3.43B$3.51B$3.44B$3.76B$3.91B
Total Liabilities$2.65B$1.61B$1.57B$1.66B$1.91B$2.09B$2.07B$2.34B$2.35B$2.58B$3.09B
Long-Term Debtn/a$993.95M$992.36M$1.13B$1.35B$1.48B$1.48B$1.73B$1.80Bn/an/a
Shareholders' Equity$1.92B$1.89B$1.83B$1.66B$1.45B$1.58B$1.36B$1.17B$1.10B$1.18B$822.55M
Cash & Equivalents$89.13M$63.87M$97.88M$46.47M$58.49M$27.18M$32.30M$94.76M$27.53M$32.55M$41.85M
Operating Cash Flow$249.40M$257.63M$251.51M$248.93M$229.72M$259.92M$235.61M$217.12M$189.28M$210.11M$148.67M
Capital Expenditures$14.04M$11.18M$8.22M$9.55M$7.78M$9.64M$22.24M$14.56M$10.48M$12.53M$2.98M
Free Cash Flow$235.36M$246.45M$243.29M$239.38M$221.93M$250.28M$213.36M$202.56M$178.80M$197.58M$145.69M
Share Repurchases$121.51M$156.28M$51.51M$25.00M$50.00M$0$11.87M$56.72M$49.98M$0$0
Weighted Average Diluted Sharesn/a48.72M50.08M50.18M49.89M50.84M50.60M51.14M52.07M53.53M53.36M
EPS (Basic)n/a$3.93$4.32$4.21-$1.65$4.09$3.28$2.81-$0.69$6.40$1.31

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView